Abacavir Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Abacavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Abacavir is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV in the blood. Abacavir Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures
Abacavir Nitroso Impurity 2 CAS NO:NA Chemically represented as N-(2-Amino-9H-purin-6-yl)-N-cyclopropylnitrous amide . Synchemia is the leading manufacturing and exporter of Abacavir Nitroso Impurity 2.We supply Abacavir Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143364 |
| CAS No | NA |
| Mol.F. | C10H10ClN5O |
| Mol.Wt. | 251.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143365 |
| CAS No | NA |
| Mol.F. | C10H12ClN5O2 |
| Mol.Wt. | 269.7 g/mole |
| INV STATUS |
| CAT No | SRC-N0143366 |
| CAS No | 924-46-9 |
| Mol.F. | C4H10N2O |
| Mol.Wt. | 102.1 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143367 |
| CAS No | NA |
| Mol.F. | C20H26N2O5 |
| Mol.Wt. | 374.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143368 |
| CAS No | NA |
| Mol.F. | C18H21N3OS |
| Mol.Wt. | 327.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143369 |
| CAS No | NA |
| Mol.F. | C15H18ClFN2O3 |
| Mol.Wt. | 328.77 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143370 |
| CAS No | NA |
| Mol.F. | C12H23N5O |
| Mol.Wt. | 253.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143371 |
| CAS No | NA |
| Mol.F. | C27H40ClFN6O2 |
| Mol.Wt. | 535.11g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143372 |
| CAS No | NA |
| Mol.F. | C27H40ClFN6O2 |
| Mol.Wt. | 535.11g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143373 |
| CAS No | NA |
| Mol.F. | C12H21N5O3 |
| Mol.Wt. | 283.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143374 |
| CAS No | NA |
| Mol.F. | C15H18F2N2O3 |
| Mol.Wt. | 312.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143375 |
| CAS No | NA |
| Mol.F. | C21H27N7O5S |
| Mol.Wt. | 489.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143376 |
| CAS No | NA |
| Mol.F. | C17H19N5O3 |
| Mol.Wt. | 341.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143377 |
| CAS No | NA |
| Mol.F. | C21H27N7O5S |
| Mol.Wt. | 489.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143378 |
| CAS No | NA |
| Mol.F. | C17H19N5O6S |
| Mol.Wt. | 421.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143379 |
| CAS No | NA |
| Mol.F. | C38H45N11O9S2 |
| Mol.Wt. | 863.97 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |